4-Trifluoromethoxyphenylboronic acid | CAS:139301-27-2

We serve 4-Trifluoromethoxyphenylboronic acid CAS:139301-27-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Trifluoromethoxyphenylboronic acid

Product Name: 4-Trifluoromethoxyphenylboronic acid
Other Name:
4-Trifluoromethoxyphenylboronic acid
(4-(Trifluoromethoxy)phenyl)boronic acid
4-(Trifluoromethoxy)benzeneboronic Acid
4-(Trifluoromethoxy)phenylboronic Acid
CAS No: 139301-27-2
MF: C7H6BF3O3
MW: 205.92700
Density: 1.41 g/cm3
Boiling point: 256.6ºC at 760 mmHg
Melting point: 123-127 °C(lit.)
Flash point: 109ºC
Refractive index: 1.461
UN Number: Not dangerous goods.
UN Proper Shipping Name: Not dangerous goods.
Transport hazard class: Not dangerous goods.
Packing group: Not dangerous goods.
 
Specification
Appearance: White to beige crystalline powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Applicationd as Sonidegib intermediate, pharmaceutical intermediate, pesticide intermediate, OLED intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 4-Trifluoromethoxyphenylboronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(Trifluoromethoxy)phenylboronic Acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(4-(Trifluoromethoxy)phenyl)boronic acid Use and application,(4-(Trifluoromethoxy)phenyl)boronic acid technical grade,usp/ep/jp grade.


Related News: “Out of an abundance of caution and based on the latest advice from leading health experts, we’re closing all our corporate offices, stores and contact centers in mainland China through February 9.”4-methylsalicylic acid manufacturer “CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.[(1R,2R)-2-(methylsulfonyloxymethyl)cyclohexyl]methyl methanesulfonate supplier More serious cases could lead to potentially deadly conditions such as pneumonia and kidney failure, with the former having been reported among some patients in China.3-Methyl-4-methylthiophenol vendor More serious cases could lead to potentially deadly conditions such as pneumonia and kidney failure, with the former having been reported among some patients in China.Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs.